These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20519148)

  • 1. Exploiting mitochondrial apoptosis for the treatment of cancer.
    Fulda S
    Mitochondrion; 2010 Nov; 10(6):598-603. PubMed ID: 20519148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrially targeted anti-cancer agents.
    Biasutto L; Dong LF; Zoratti M; Neuzil J
    Mitochondrion; 2010 Nov; 10(6):670-81. PubMed ID: 20601192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria as therapeutic targets for the treatment of malignant disease.
    Fulda S; Kroemer G
    Antioxid Redox Signal; 2011 Dec; 15(12):2937-49. PubMed ID: 21644835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
    Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
    Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy: targeting the mitochondrial cell death pathway.
    Debatin KM; Poncet D; Kroemer G
    Oncogene; 2002 Dec; 21(57):8786-803. PubMed ID: 12483532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondriotoxic compounds for cancer therapy.
    Fantin VR; Leder P
    Oncogene; 2006 Aug; 25(34):4787-97. PubMed ID: 16892091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of AIF-mediated caspase-independent programmed cell death.
    Lorenzo HK; Susin SA
    Drug Resist Updat; 2007 Dec; 10(6):235-55. PubMed ID: 18180198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of caspase-8 in chemotherapy-induced apoptosis of patient derived leukemia cell lines independent of the death receptor pathway and downstream from mitochondria.
    de Vries JF; Wammes LJ; Jedema I; van Dreunen L; Nijmeijer BA; Heemskerk MH; Willemze R; Falkenburg JH; Barge RM
    Apoptosis; 2007 Jan; 12(1):181-93. PubMed ID: 17136321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria: A novel target for the chemoprevention of cancer.
    Hail N
    Apoptosis; 2005 Aug; 10(4):687-705. PubMed ID: 16133861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis.
    Fulda S; Meyer E; Friesen C; Susin SA; Kroemer G; Debatin KM
    Oncogene; 2001 Mar; 20(9):1063-75. PubMed ID: 11314043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis.
    Wang P; Song JH; Song DK; Zhang J; Hao C
    Cell Signal; 2006 Sep; 18(9):1528-35. PubMed ID: 16442262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting mitochondrial permeability in cancer drug development.
    Berridge MV; Herst PM; Lawen A
    Mol Nutr Food Res; 2009 Jan; 53(1):76-86. PubMed ID: 19035550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis repressor with caspase recruitment domain contributes to chemotherapy resistance by abolishing mitochondrial fission mediated by dynamin-related protein-1.
    Wang JX; Li Q; Li PF
    Cancer Res; 2009 Jan; 69(2):492-500. PubMed ID: 19147562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential induction of apoptosis and MAP kinase signaling by mitochondrial toxicants in drug-sensitive compared to drug-resistant B-lineage lymphoid cell lines.
    O'Brien KA; Muscarella DE; Bloom SE
    Toxicol Appl Pharmacol; 2001 Aug; 174(3):245-56. PubMed ID: 11485385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting mitochondria for cancer therapy.
    Hockenbery DM
    Environ Mol Mutagen; 2010 Jun; 51(5):476-89. PubMed ID: 20213841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms.
    Reed JC
    Nat Clin Pract Oncol; 2006 Jul; 3(7):388-98. PubMed ID: 16826219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis induction by a novel anti-prostate cancer compound, BMD188 (a fatty acid-containing hydroxamic acid), requires the mitochondrial respiratory chain.
    Joshi B; Li L; Taffe BG; Zhu Z; Wahl S; Tian H; Ben-Josef E; Taylor JD; Porter AT; Tang DG
    Cancer Res; 1999 Sep; 59(17):4343-55. PubMed ID: 10485482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective anticancer strategies via intervention of the death pathways relevant to cell transformation.
    Li QX; Yu DH; Liu G; Ke N; McKelvy J; Wong-Staal F
    Cell Death Differ; 2008 Aug; 15(8):1197-210. PubMed ID: 18437165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Betulin induces mitochondrial cytochrome c release associated apoptosis in human cancer cells.
    Li Y; He K; Huang Y; Zheng D; Gao C; Cui L; Jin YH
    Mol Carcinog; 2010 Jul; 49(7):630-40. PubMed ID: 20564340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway.
    Yang X; Fraser M; Moll UM; Basak A; Tsang BK
    Cancer Res; 2006 Mar; 66(6):3126-36. PubMed ID: 16540663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.